EBR Systems (EBRCZ) FCF Margin (2025 - 2026)
EBR Systems' (EBRCZ) quarterly FCF Margin came in at 996.66% in Q1 2026, up 43.4% quarter-over-quarter from 1760.83% in Q4 2025.
Analysis
EBR Systems (EBRCZ) FCF Margin (2025 - 2026) Analysis & Trends
EBR Systems has disclosed FCF Margin across 2 years of filings, most recently posting 996.66% for Q1 2026.
- In Q1 2026, FCF Margin changed N/A year-over-year to 996.66%; the TTM figure through Mar 2026 stood at 1678.61% (changed N/A YoY), while the FY2025 annual figure was 3517.32%, changed N/A from the prior year.
- FCF Margin came in at 996.66% for Q1 2026 at EBR Systems, up from 1760.83% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 996.66% in Q1 2026 to a low of 7286.23% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | EBR Systems | 10.83 Mn | 10.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -996.66% |
| Dec 31, 2025 | -1,760.83% |
| Sep 30, 2025 | -2,815.62% |
| Jun 30, 2025 | -7,286.23% |